Shari Geffon brings over 25 years of industry experience to renegade.bio, with senior-level roles in development operations, project and portfolio management, and organizational development in diagnostics, biotech, and pharmaceuticals.
Shari has led R&D teams working on small molecule, biologic and drug-device combination products in immunology, neurology, and oncology. She has also led large-scale organizational development initiatives at Elan, Pfizer, Stiefel, and FibroGen and served as Chief of Staff on multiple worldwide M&A integrations.
Shari holds an MBA and a B.Sc. in Biological Science.